These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37787267)

  • 1. Meta-analysis of Genetic polymorphism of Enhancer of Zeste Homolog2 gene in cancer susceptibility.
    Gautam N; Kaur M; Kashyap S
    J Cancer Res Ther; 2023; 19(5):1079-1092. PubMed ID: 37787267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features.
    Yu YL; Su KJ; Hsieh MJ; Wang SS; Wang PH; Weng WC; Yang SF
    PLoS One; 2014; 9(4):e93635. PubMed ID: 24691023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of protein tyrosine phosphatase, non-receptor type 22 +1858C→T polymorphism and susceptibility to vitiligo: Systematic review and meta-analysis.
    Agarwal S; Changotra H
    Indian J Dermatol Venereol Leprol; 2017; 83(2):183-189. PubMed ID: 28164884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.
    Yu YL; Su KJ; Hsieh YH; Lee HL; Chen TY; Hsiao PC; Yang SF
    PLoS One; 2013; 8(9):e74870. PubMed ID: 24040354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP19 gene rs2414096 variant and differential genetic risk of polycystic ovary syndrome: a systematic review and meta-analysis.
    Sharma P; Kaur M; Khetarpal P
    Gynecol Endocrinol; 2021 Feb; 37(2):126-131. PubMed ID: 32856958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between SULT1A1 Arg213His (rs9282861) Polymorphism and Risk of Breast Cancer: A Systematic Review and Meta-Analysis.
    Forat-Yazdi M; Jafari M; Kargar S; Abolbaghaei SM; Nasiri R; Farahnak S; Foroughi E; Neamatzadeh H
    J Res Health Sci; 2017 Oct; 17(4):e00396. PubMed ID: 29233949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies.
    Zhou C; Zou X; Wen X; Guo Z
    PLoS One; 2022; 17(7):e0271265. PubMed ID: 35839271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis.
    He Y; Xu X; Chen H; Wang J; Xiong W; Xu Y; Liu J
    Gene; 2013 Jul; 523(2):199-204. PubMed ID: 23587910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancer of zeste 2 polycomb repressive complex 2 subunit polymorphisms in melanoma skin cancer risk.
    Belpinati F; Malerba G; Dal Toè M; Ceccuzzi L; Rodolfo M; Poli A; Turco A; Vergani E; Sangalli A; Gomez-Lira M
    Exp Dermatol; 2020 Oct; 29(10):980-986. PubMed ID: 32748461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
    Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
    Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of the iNOS gene polymorphism with risk of cancer: a systematic review and Meta-Analysis.
    Jiao J; Wu J; Huang D; Liu L
    Sci Rep; 2015 Sep; 5():9889. PubMed ID: 26391304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of
    Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between EZH2 Genetic Variants and Hepatocellular Carcinoma in a Chinese Han Population.
    Li S; Sun S; Yu S; Dong Z; Jiang K; Xiang L; Li H
    Clin Lab; 2018 Jan; 64(1):85-91. PubMed ID: 29479874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 Expression and Survival for ER+/tamoxifen Treated Breast Cancer Patients with rs2302427 C>G: A Novel Prognostic and Risk Predictive Biomarker.
    Gautam N; Kaur S; Kashyap S
    Arch Med Res; 2023 Jul; 54(5):102852. PubMed ID: 37438214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of four single nucleotide polymorphisms of
    Ling Z; You Z; Hu L; Zhang L; Wang Y; Zhang M; Zhang G; Chen S; Xu B; Chen M
    Onco Targets Ther; 2018; 11():851-865. PubMed ID: 29497317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.
    Aziz MA; Jafrin S; Islam MS
    Hum Cell; 2021 Jul; 34(4):1066-1081. PubMed ID: 33743166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis.
    Mandal RK; Yadav SS; Panda AK
    Tumour Biol; 2014 Sep; 35(9):8607-13. PubMed ID: 24863946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the BRCA2 rs144848 polymorphism and cancer susceptibility: a meta-analysis.
    Li Q; Guan R; Qiao Y; Liu C; He N; Zhang X; Jia X; Sun H; Yu J; Xu L
    Oncotarget; 2017 Jun; 8(24):39818-39832. PubMed ID: 28418854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.